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Objectives: The Korea HIV/AIDS cohort was constructed with 18 hospitals that
care for HIV-infected individuals in 2006. We compared the epidemiological and
immunological characteristics of the cohort registrants with those of the HIV-
infected population at the time of HIV diagnosis.
Methods: This study was conducted on 5717 people living with HIV/AIDS from
1985 to 2009, of which 789 individuals registered with the Korea HIV/AIDS cohort
study. Individuals who had data from initial CD4þ T-cell counts measured within
6 months following HIV diagnosis were selected as study participants to predict
the status of disease progression at the time of HIV diagnosis. A total of 2886
patients (50%) were selected from people living with HIV/AIDS, of whom 424
individuals (54%) were cohort registrants. The c2 test and Wilcoxon rank sum test
were used for analysis.
Results: The distributions of age, marital status, diagnosed regions, reason for
HIV testing, and screening site were similar between the HIV-infected population
and the cohort registrants. In 1985e2004, the male ratio for the cohort regis-
trants (94.3%) was significantly higher than that measured for the HIV-infected
population (89.5%) (pZ 0.0339). With regard to transmission route, homosexual
contact of cohort registrants (46.6%) was higher than that of the HIV-infected
population (40.1%) (p Z 0.022) in 2005e2009. No statistical difference in
CD4þ T-cell counts at the time of HIV diagnosis was found between the HIV-
infected population and cohort registrants (p Z 0.2195).
Conclusion: The Korea HIV/AIDS cohort registrants represent the HIV-infected
population, and the data collected from this cohort could be used as a founda-
tion for national statistics.ted under the terms of the Creative Commons Attribution Non-Commercial License (http://
) which permits unrestricted non-commercial use, distribution, and reproduction in any
operly cited.
his work.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
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Since the first HIV infection was discovered in 1985,
a total of 8535 HIV-infected individuals have been
identified as of the end of December 2011, and 7032
people living with HIV/AIDS (PLWHA, 82%) of those
infected are in Korea [1]. Recently, approximately
700e800 HIV-infected individuals have been identified
each year, and it is expected that the number of PLWHA
will exponentially increase in the future. HIV infection
causes lifelong loss cost of approximately US$400,000
per individual, causing both personal and national
socioeconomic burdens [2]. Therefore, it is important to
develop strategies to prevent HIV infection.
In Korea, HIV-infected individuals have been
managed by the government according to the HIV
Prevention Act. In addition, the national and local
governments support the cost associated with AIDS
treatment and HIV-related tests. However, clinical
information and treatment data obtained are managed by
hospitals, whereas their diagnostic and epidemiologic
data are managed by the Korea Centers for Disease
Control and Prevention (KCDC). Thus, the national
statistics calculated by integrating the data from HIV-
infected individuals and the utilization of relevant
information for HIV/AIDS research have been limited.
In addition, as the protection of individual privacy has
been increasingly emphasized since the enforcement of
the Bioethics and Safety Act in 2005, it has become
mandatory to obtain informed consent forms from
participants when samples and data from the participants
are collected for HIV/AIDS research [3].
In developed countries, the HIV/AIDS cohort has
been in existence since the 1980s, allowing for
significant outcomes in the areas of HIV diagnostic
technology, treatment, and other researches [4e7]. In
particular, the Swiss HIV Cohort Study (SHCS) is an
open cohort in which HIV-infected individuals are
continuously registered as participants [5]. Forty-five
percent of the total Swiss HIV-infected individuals and
69% of AIDS patients are registered as SHCS partici-
pants, allowing for the results of the cohort studies to
be directly utilized for the control of national policies on
HIV/AIDS prevention. With reference to the SHCS, the
KCDC constructed the Korea HIV/AIDS cohort with 18
hospitals that care for HIV-infected individuals in 2006
[9]. Cohort registrants are recruited among HIV-infected
individuals over 18 years old who undergo treatments in
the aforementioned hospitals. A follow-up is conducted
every 6 months, and the blood samples and relevant
data from the registrants are sent to the KCDC. Since the
establishment of the Korea HIV/AIDS cohort study,
approximately 850 HIV-infected individuals have been
registered to the cohort during a 5-year period (2007e
2011). A basic study for correcting and minimizing bias
is required before utilization of the data and samples
from the cohort study and the application of the resultsto future HIV/AIDS prevention polices. Moreover, when
recruiting new registrants to the open cohort, basic data
are needed to adjust for the representation of the cohort
registrants for the HIV-infected population upon regis-
tration to the cohort. For these reasons, we compared the
epidemiological and immunological characteristics of
the cohort registrants with those of the HIV-infected
population at the baseline, which is the time of HIV
diagnosis.2. Materials and Methods
2.1. Subjects
If an individual is diagnosed with an HIV infection
through the national HIV surveillance system in Korea,
it is reported to the KCDC. The KCDC conducts an HIV
epidemiologic survey through public health centers and
manages the collected data via the HIV database(DB)
system. In addition, the KCDC conducts immunological
tests to assess the progression status of the disease when
patients are diagnosed with HIV infection, and manages
the results with the HIV laboratory information
management system (LIMS) [8].
This study was conducted on 5717 PLWHA from
a total of 6883 HIV-diagnosed individuals who have
been registered from 1985 to 2009, of whom 789 indi-
viduals registered with the Korea HIV/AIDS cohort
study. We defined 5717 PLWHA as the HIV-infected
population in this study. Individuals who had data from
the initial CD4þ T-cell count measured within 6 months
after the diagnosis of HIV infection were selected as
participants to predict the status of disease progression
at the time of HIV diagnosis. A total of 2886 patients
(50%) were selected among PLWHA, of whom 424
individuals (54%) were cohort registrants.
2.2. Statistical analysis
The following variables were compared between the
HIV-infected population and the Korea HIV/AIDS
cohort registrants using epidemiological data and the
CD4þ T-cell counts managed by the HIV DB system
and the HIV laboratory information system in KCDC,
respectively: gender, age, transmission route, marital
status, diagnosed region, screening site, reason for HIV
testing, and diagnosed year for HIV infection.
The proportion of HIV/AIDS cohort registrants for
the HIV-infected population by year of diagnosis is
shown in Table 1. Because we registered the Korea
HIV/AIDS cohort participants from 2007 and tried to
recruit recently diagnosed individuals, the HIV-infected
individuals after the diagnosed year of 2005 were
actively registered in the Korea HIV/AIDS cohort
(Table 1). For this reason, we compared the character-
istics of those who belong to the HIV-infected pop-
ulation and the cohort registrants by dividing them into
two groups: 1985e2004 and 2005e2009.
Table 1. Distribution of the HIV-infected population and the Korea HIV/AIDS cohort registration by year of HIV diagnosis
Year of
diagnosis
HIV-infected
population*, N (%)
HIV/AIDS cohort
registrants N (%)
Year of cohort registration
2007 2008 2009 2010 2011
2000 762 (13.3) 84 (10.9) 18 35 7 23 1
2001 243 (4.3) 26 (3.3) 6 10 3 5 2
2002 336 (5.9) 36 (4.6) 3 12 11 10 0
2003 455 (8.0) 58 (7.4) 12 21 8 16 1
2004 530 (9.3) 63 (8.0) 26 24 4 9 0
2005 597 (10.4) 90 (11.4) 23 33 10 23 1
2006 663 (11.6) 114 (14.4) 46 41 11 16 0
2007 682 (11.9) 109 (13.8) 31 40 14 23 2
2008 743 (13.0) 130 (16.5) 0 66 28 32 3
2009 706 (12.3) 79 (10.0) 0 0 46 32 1
Total 5,717 789 165 282 142 189 11
*HIV-infected population: people living with HIV/AIDS from 1985 to 2009.
102 J.-H. Lee, et alWith regard to individuals age, the age at the time of
HIV diagnosis was used. As for marital status, divorce
or separation by death at the time of HIV diagnosis was
classified as married. For the diagnosed regions, seven
big cities and the remaining areas were classified into
metropolitan cities and small towns or rural areas,
respectively. Screening sites were classified into three
groups: public institutions, hospitals, and blood banks.
For HIV transmission routes, sexual contact were clas-
sified into two groups: heterosexual and homosexual.
Infection by blood transfusion or blood products and
mother-to-child transmission were classified as others.
For reason for HIV testing, reasons at the time of HIV
screening were used, which followed the classification
criteria of a previous study [10].
To compare the epidemiological characteristics of the
cohort registrants with the HIV-infected population by
the year of HIV diagnosis, c2 test was conducted for
each epidemiologic variable. To compare the status of
disease progression at the time of HIV diagnosis, Wil-
coxon rank sum test was performed for the difference in
measured CD4þ T-cell counts. A significance level of
0.05 was used for statistical testing, and results were
analyzed using the SAS 9.1 version software.3. Results
3.1. Epidemiological characteristics of
HIV-infected populations and of HIV/AIDS
cohort registrants
The epidemiological characteristics of HIV-infected
population are presented in Table 2. Approximately
92% of the HIV-infected population was male, and
individuals in the 30s accounted for the largest pop-
ulation (32.2%). The transmission route was mainly
caused by sexual contact; heterosexual contact (59.3%)
was higher than homosexual contact (40.1%). As formarital status, unmarried individuals (62.5%) accounted
for a larger percentage of the study individuals (married
individuals comprised 37.5%). As for the diagnosed
region, metropolitan cities (69.6%) accounted for the
higher percentage of individuals than those reported for
small towns and rural areas (30.4%). The individuals
were diagnosed with HIV testing for clinical manifes-
tation (39.4%), health checkup (26.8%), and knowledge
of status (14.2%). The hospital accounted for the largest
portion (68%) of screening sites, followed by public
institution (22.2%).
Comparison of epidemiological characteristics,
wherein individuals were divided into two groups
according to the year of diagnosis, demonstrated
differences in gender, age, reason for HIV testing, and
screening site. Compared with the 1985e2004 group,
the both percentages of males and the older age of
HIV diagnosis are higher in the 2005e2009 group. In
addition, clinical manifestation is the major reason for
initial HIV testing, and voluntary testing for knowl-
edge of status accounted for a larger percentage in
the 2005e2009 group compared to the 1985e2004
group.
Table 3 compares the epidemiological characteristics
of the cohort registrants and the HIV-infected pop-
ulation. The distributions including age, marital status,
diagnosed region, reason for HIV testing, and screening
site were similar between the HIV-infected population
and the cohort registrants. The HIV-infected population
in 1985e2004 is 40.7% (2326 individuals) of the total,
while that of cohort registrants is lower (33.8%, 267
individuals), and the male was significantly higher in the
cohort registrants (94.3%) than in the HIV-infected
population (89.5%) (p Z 0.0339). However, for the
transmission route, homosexual contact in the cohort
registrants (46.6%) was higher than that of the HIV-
infected population (40.1%) from 2005 to 2009
(p Z 0.022).
Table 2. Comparison of epidemiological characteristics of the HIV-infected population by year of HIV diagnosis
Category Total N (%)
Year of HIV diagnosis
P-value1985-2004, N (%) 2005-2009, N (%)
Total 5,717 2,326 (40.7) 3,391 (59.3)
Gender <.0001
Male 5,241 (91.7) 2,082 (89.5) 3,159 (93.2)
Female 476 (8.3) 244 (10.5) 232 (6.8)
Age <.0001
29 1,551 (27.1) 732 (31.5) 819 (24.2)
30-39 1,840 (32.2) 838 (36.0) 1,002 (29.5)
40-49 1,311 (22.9) 468 (20.1) 843 (24.9)
50 1,015 (17.8) 288 (12.4) 727 (21.4)
Transmission route 0.7253
Hetrosexual 2,901 (59.3) 1,277 (58.6) 1,624 (59.8)
Homosexual 1,965 (40.1) 875 (40.2) 1,090 (40.1)
Others1 29 (0.6) 27 (1.2) 2 (0.1)
Marital status 0.9606
Married2 1,164 (37.5) 488 (37.5) 676 (37.5)
Unmarried 1,941 (62.5) 812 (62.5) 1,129 (62.5)
Diagnosed region 0.0951
Metropolitan city 3,978 (69.6) 1,647 (70.8) 2,331 (68.7)
Small town and rural 1,739 (30.4) 679 (29.2) 1,060 (31.3)
Reason for HIV testing3 <.0001
Health check-up 1,273 (26.8) 488 (29.7) 785 (25.3)
Knowledge of status 673 (14.2) 211 (12.8) 462 (14.9)
Risky behavior 441 (9.3) 302 (18.4) 139 (4.5)
Clinical manifestation 1,870 (39.4) 385 (23.4) 1,485 (47.8)
Blood donor 492 (10.3) 258 (15.7) 234 (7.5)
Screening site <.0001
Public institution 1,271 (22.2) 689 (29.6) 582 (17.2)
Hospital 3,888 (68.0) 1,366 (58.7) 2,522 (74.4)
Blood bank 558 (9.8) 271 (11.7) 287 (8.5)
1Others: Infection by blood transfusion or blood products, and mother to child transmission; 2Married: Include divorce or separation by death at the time of
HIV diagnosis; 3Reason for HIV test: Reasons at the time of HIV screening.
HIV-infected population: People living with HIV/AIDS from 1985 to 2009.
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HIV-infected population and of HIV/AIDS
cohort registrants
The median value of CD4þ T-cell counts for the
cohort registrants during 1985e2004 (348 cells/mm3,
interquartile range: 225e496) was statistically higher
than that in the 2005e2009 group (275 cells/mm3,
interquartile range: 160e413) (p < 0.0001; data not
shown). The comparison of the distribution of CD4þ
T-cell counts at the time of HIV diagnosis between the
HIV-infected population and the cohort registrants are
presented in Figure 1. Meanwhile, as compared to the
immune level distribution of the HIV-infected pop-
ulation, the cohort registrants in the 1985e2004 group
showed a higher level (200e349 cells/mm3), although
no statistical significance was found between two groups(p Z 0.5732). In addition, the cohort registrants in the
2005e2009 group exhibited increased levels, <200 and
200e349 cells/mm3, than the HIV-infected population;
however, no statistical significance was found between
two groups (p Z 0.2195).4. Discussion
The Joint United Nations Programme on HIV/AIDS
has estimated that, since the first HIV case was reported
in 1981, the number of PLWHA has reached 33.3
million (31.4e35.3 million) by the end of 2009. The
male to female ratio of HIV-infected individuals is
almost 1:1, and individuals aged younger than 15 years
accounted for 7% of the total [11].
Table 3. Comparison of the epidemiological characteristics of the Korea HIV/AIDS cohort registrants with the HIV-infected population by the year of HIV diagnosis
Category
1985-2004 2005-2009
HIV-infected
population*, N (%)
HIV/AIDS Cohort
registrant N (%) P-value
HIV-infected
population*, N (%)
HIV/AIDS Cohort
registrant, N (%) P-value
Total 2,326 267 3,391 522 <.0001
Gender 0.0339 0.3517
Male 2,082 (89.5) 250 (93.6) 3,159 (93.2) 492 (94.3)
Female 244 (10.5) 17 (6.4) 232 (6.8) 30 (5.7)
Age 0.7509 0.4259
29 732 (31.5) 86 (32.2) 819 (24.2) 113 (21.6)
30-39 838 (36.0) 89 (33.3) 1,002 (29.5) 161 (30.8)
40-49 468 (20.1) 60 (22.5) 843 (24.9) 124 (23.8)
50 288 (12.4) 32 (12.0) 727 (21.4) 124 (23.8)
Transmission route 0.3972 0.022
Hetrosexual 1,277 (58.6) 140 (54.3) 1,624 (59.8) 240 (53.2)
Homosexual 875 (40.2) 114 (44.2) 1,090 (40.1) 210 (46.6)
Others1 27 (1.2) 4 (1.5) 2 (0.1) 1 (0.2)
Marital status 0.5381 0.3503
Married2 488 (37.5) 59 (40.1) 676 (37.5) 122 (40.3)
Unmarried 812 (62.5) 88 (59.9) 1,129 (62.5) 181 (59.7)
Diagnosed region 0.2526 0.4387
Metropolitan city 1,647 (70.8) 198 (74.2) 2,331 (68.7) 350 (67.0)
Small town and rural 679 (29.2) 69 (25.8) 1,060 (31.3) 172 (33.0)
Reason for HIV testing3 0.5179 0.4296
Health check-up 488 (29.7) 51 (28.2) 785 (25.3) 127 (26.1)
Knowledge of status 211 (12.8) 26 (14.4) 462 (14.9) 71 (14.6)
Risky behavior 302 (18.4) 25 (13.8) 139 (4.5) 17 (3.5)
Clinical manifestation 385 (23.4) 46 (25.4) 1,485 (47.8) 244 (50.2)
Blood donor 258 (15.7) 33 (18.2) 234 (7.5) 27 (5.6)
Screening site 0.433 0.1486
Public institution 689 (29.6) 69 (25.8) 582 (17.2) 76 (14.6)
Hospital 1,366 (58.7) 166 (62.2) 2,522 (74.4) 409 (78.3)
Blood bank 271 (11.7) 32 (12.0) 287 (8.4) 37 (7.1)
*HIV-infected population: HIV-infected population: people living with HIV/AIDS from 1985 to 2009; 1Others: Infection by blood transfusion or blood products, and mother to child transmission; 2Married: include divorce or
separation by death at the time of HIV diagnosis; 3Reason for HIV test: Reasons at the time of HIV screening.
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Figure 1. Comparison of CD4þ T-cell counts at the time of HIV diagnosis between the HIV-infected population and Korea
HIV/AIDS cohort registrants in (A) 1985e2004 and (B) 2005e2009.
Epidemiological and immunological characteristics of Korea HIV/AIDS cohort registrants 105In Korea, the number of HIV-infected individuals has
continuously increased, and more than 700 infected
individuals have recently been diagnosed every year.
Most HIV-infected Koreans are male (male to female
ratio 11:1), of whom more than 99% received HIV
through sexual contact. Majority of infected individuals
have been diagnosed through HIV testing due to clinical
manifestation, and in agreement with a previous study
[10]. The incidence of late diagnosis has steadily
increased. In addition, the proportions of males and of
older age at diagnosis have also rised.
So far, HIV prevalence has been low [12], but the
number of PLWHA in Korea has reached a total of more
than 7000 as of 2011. Therefore, AIDS prevention
policies including the reduction of HIV transmission,
and the promotion of a healthy lifestyle for HIV-infected
individuals have been increasingly required. Accord-
ingly, the Korean government has managed various
programs including the early diagnosis of HIV infection,
support for the treatment of HIV-infected individuals,
and counseling. However, for the establishment and
evaluation of HIV prevention policies efficiently,
scientific evidence is required.
For example, in the US, the Multicenter AIDS Cohort
Study (1984) for male homosexuals and the Women’s
Interagency HIV Study (1994) for female heterosexuals
have already been established [13,14]. The results of the
HIV/AIDS cohort studies were applied to national
programs for HIV prevention as well as to diagnostic and
treatment guidelines for HIV-infected individuals, and
the development of therapeutic drugs, thereby extending
the survival of infected individuals and preventing the
transmission of HIV infection [15,16]. In Europe, the
multinational cohort, Concerted Action on SeroConver-
sion to AIDS and Death in Europe (1997), in which 12
countries participated, was established for individuals
whose HIV infection time can be predicted [17].
In Korea, HIV prevalence was very low and the pool
of HIV researchers was also small before 2000. Thus,
the HIV studies representing the HIV-infected population,such as survival rate, therapeutic effects, and clinical
characteristics were insufficient. However, as the
number of HIV-infected individuals has increased since
2000, the Korea HIV/AIDS cohort study was established
in 2006 to obtain basic data that can be applied to the
establishment of preventive policies based on scientific
evidence and to construct an infrastructure that promotes
HIV/AIDS studies under the system that financially
supports HIV-infected individuals.
In this study, we evaluated whether the cohort
registrants represent the HIV-infected population. The
results demonstrate that gender and transmission routes
are different from the HIV-infected population. Before
2005, the percentage of males is higher in cohort
registrants than in the HIV-infected population. This is
a direct result of the different distribution of the diag-
nosed year in the cohort registrant and the recently
increased proportion of males in the HIV-infected pop-
ulation in Korea. In particular, the major transmission
route of recently identified infected individuals was
homosexual contact, which is higher than that reported
for the HIV-infected population.
Following the results of HIV epidemiologic survey,
the male to female ratio of the HIV-infected population
is 11:1, and the proportion of those infected through
heterosexual contact is steadily higher than that of
homosexual contact. However, the answer to the trans-
mission route was occasionally changed in the next
survey, and an accurate analysis is required for the
survey regarding the route of transmission. The
comparison of the CD4þ T-cell counts at the time of
HIV diagnosis between HIV-infected population and the
cohort registrants indicated that the progression of HIV
is similar between the two groups.
In addition, the results for the comparison of the time
taken to register with the cohort study after the HIV
diagnosis demonstrated that the cohort registration
proportion was 30% and 57% within 1 and 3 years after
the diagnosis of HIV infection, respectively (Table 4).
As soon as the infected individuals are diagnosed, they
Table 4. Time interval between the cohort registration
and the HIV diagnosis of Korea HIV/AIDS
cohort registrants
Periods (year) Frequency Percentage
1 year 244 30.9
1-3years 215 27.3
4-5years 132 16.7
6-10 years 147 18.6
>10 years 51 6.5
Cohort registrants: HIV/AIDS cohort registrants registered from 2007
to 2011 in people living with HIV/AIDS.
106 J.-H. Lee, et alare treated in the hospital according to the guideline
established for HIV/AIDS in recent years [1]. Therefore,
the period between the HIV diagnosis and cohort
registration will be decreased.
No significant difference in the epidemiological and
immunological criteria was found between the HIV-
infected population and cohort registrants. Our results
indicated that the Korea HIV/AIDS cohort registrants
represent the HIV-infected population, and that the data
collected from this cohort can be used as a foundation
for national statistics. We also suggest that selection bias
in the cohort study should be checked continuously for
the maintenance of a representative sampling.Acknowledgement
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